Legal Representation
Attorney
Gabriel M. Gillmeyer
USPTO Deadlines
Next Deadline
89 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 29, 2025
Extension Available
Until October 29, 2025
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 26, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 26, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 26, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 26, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 26, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 4, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Apr 29, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 29, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 29, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 23, 2024 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 19, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 3, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for therapeutic use, protein-based toxins for therapeutic use, protein-based toxins generated in an in vitro cell-free expression system for therapeutic and medical research uses; Research and development in the field of bioinformatics and production of protein-based toxins having therapeutic applications; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development of new toxin compounds for therapeutic use, namely, new protein-based toxins for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for diagnostic use, protein-based toxins for diagnostic use, protein-based toxins generated in an in vitro cell-free expression system for diagnostic and medical research uses
Classification
International Classes
042